Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
103.87
-4.10 (-3.80%)
Feb 5, 2026, 4:00 PM EST - Market closed
Rhythm Pharmaceuticals Stock Forecast
Stock Price Forecast
The 13 analysts that cover Rhythm Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $129.92, which forecasts a 25.08% increase in the stock price over the next year. The lowest target is $94 and the highest is $167.
Price Target: $129.92 (+25.08%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Rhythm Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 8 | 8 | 8 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 13 | 13 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $129 → $145 | Buy | Maintains | $129 → $145 | +39.60% | Jan 20, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $123 → $125 | Strong Buy | Maintains | $123 → $125 | +20.34% | Jan 20, 2026 |
| Needham | Needham | Strong Buy Maintains $145 → $148 | Strong Buy | Maintains | $145 → $148 | +42.49% | Jan 9, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $110 → $123 | Strong Buy | Maintains | $110 → $123 | +18.42% | Dec 22, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $120 → $140 | Strong Buy | Maintains | $120 → $140 | +34.78% | Dec 17, 2025 |
Financial Forecast
Revenue This Year
192.56M
from 130.13M
Increased by 47.98%
Revenue Next Year
300.53M
from 192.56M
Increased by 56.07%
EPS This Year
-3.25
from -4.34
EPS Next Year
-2.75
from -3.25
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 203.7M | 347.0M | ||||
| Avg | 192.6M | 300.5M | ||||
| Low | 181.6M | 257.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 56.5% | 80.2% | ||||
| Avg | 48.0% | 56.1% | ||||
| Low | 39.5% | 33.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -3.14 | -2.08 | ||||
| Avg | -3.25 | -2.75 | ||||
| Low | -3.27 | -3.58 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.